The basement membrane matrix in malignancy

Journal of Pathology

Volumn 200, Issue 4, 2003, Pages 465-470

  Engbring, Jean A ^a   Kleinman, Hynda K ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Basement membrane; Extracellular matrix; Laminin; Metastasis

Indexed keywords

GLYCOPROTEIN; LAMININ; TUMOR PROMOTER;

ANGIOGENESIS; BASEMENT MEMBRANE; BLOOD VESSEL WALL; BREAST CANCER; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; EPITHELIUM CELL; EXTRACELLULAR MATRIX; EXTRAVASATION; LUNG CANCER; LYMPH VESSEL; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; METASTASIS; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; TUMOR CELL;

BASEMENT MEMBRANE; CELL ADHESION; EXTRACELLULAR MATRIX; FIBRONECTINS; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HUMANS; LAMININ; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0038236716     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1396     Document Type: Review

References (74)

1. Pupa SM, Menard S, Ford S, et al. New insights into the role of extracellular matrix during tumor onset and progression. J Cell Physiol 2002; 192: 259-267.
2. Kleinman HK, Koblinsky J, Lee S, et al. Role of basement membrane in tumor growth and metastasis. Surg Oncol Clin North Am 2001; 10: 329-337.
3. Matrisian LM. Cancer biology: extracellular proteases in malignancy. Curr Biol. 1999; 9: 776-778.
4. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore. Curr Opin Cell Biol. 2001; 13: 534-540.
5. Rohrbach DH, Timpl R. Molecular and cellular aspects of basement membranes. In Cell Biology: A Series of Monographs. Academic Press: New York, 1993.
6. Vlodavsky I, Fuks Z, Ishai-Michaeli R, et al. Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis. J Cell Biochem. 1991; 45: 167-176.
7. Kleinman HK, McGarvey ML, Hassell JR, et al. Basement membrane complexes with biological activity. Biochemistry 1986; 25: 312-318.
8. Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-3245.
9. Fridman R, Kibbey MC, Royce LS, et al. Basement membrane (matrigel) enhances both the incidence and growth of subcutaneously injected human and murine cells. J Natl Cancer Inst 1991; 83: 769-774.
10. Colognato H, Yurchenco PD. Form and function: the laminin family of heterotrimers. Dev Dyn 2000; 218: 213-234.
11. Spessotto P, Yin Z, Magro G, et al. Laminin isoforms 8 and 10 are primary components of the subendothelial basement membrane promoting interaction with neoplastic lymphocytes. Cancer Res 2001; 61: 339-347.
12. Jun SH, Thompson EW, Gottardis M, et al. Laminin adhesion-selected primary human colon cancer cells are more tumorigenic than the parental and non adherent cells. Int J Oncol 1994; 4: 55-60.
13. Powell SK, Kleinman HK. Neuronal laminins and their cellular receptors. Int J Biochem Cell Biol 1997; 29: 401-414.
14. Graf J, Iwamoto Y, Martin GR, et al. Identification of an amino acid sequence in laminin mediating cell attachment, chemotaxis and receptor binding. Cell 1987; 489: 989-996.
15. Iwamoto Y, Robey FA, Graf J, et al. YIGSR a pentapeptide from the B1 chain of laminin inhibits tumor cell metastases. Science 1987; 238: 1132-1134.
16. Sakamoto N, Iwahana M, Tanaka NG, et al. Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2. Cancer Res 1991; 51: 903-906.
17. Yamamura K, Kibbey MC, Kleinman HK. Melanoma cells selected for adhesion to laminin peptides have different malignant properties. Cancer Res 1993; 53: 423-428.
18. Kanemoto T, Reich R, Greatorex D, et al. Identification of an amino acid sequence from the laminin A chain which stimulates metastases formation and collagenase IV production. Proc Natl Acad Sci USA 1990; 87: 2279-2283.
19. Grant DS, Kinsella JL, Fridman R, et al. Interaction of endothelial cells with a laminin A chain peptide (SIKVAV) in vitro and induction of angiogenic behavior in vivo. J Cell Physiol 1992; 153: 614-625.
20. Kibbey MC, Grant DS, Kleinman HK. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J Natl Cancer Inst 1992; 84: 1633-1638.
21. Stack MS, Gray RD, Pizzo SV. Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived for the laminin A chain. Cancer Res 1993; 53: 1998-2004.
22. Malinda KM, Nomizu M, Chung M, et al. Identification of laminin alpha-1 and beta-1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting. FASEB J 1999; 13: 53-62.
23. Ponce ML, Nomizu M, Delgado MC, et al. Identification of endothelial cell binding sites on the laminin gamma-1 chain. Cirr Res 1999; 84: 688-694.
24. Ponce ML, Nomizu M, Kleinman HK. An angiogenic laminin gamma-1 site and its antagonist bind through the αvβ3 and α5β1 integrins. FASEB J 2001; 15: 1389-1397.
25. Kim WH, Nomizu M, Song SY, et al. Laminin-alpha1-chain sequence Leu-Gln-Val-Gln-Leu-Ser-Ile-Arg (LQVQLSIR) enhances murine melanoma cell metastases. Int J Cancer 1998; 77: 632-639.
26. Engbring JA, Hoffman MP, Karmand AJ, et al. The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan. Cancer Res 2002; 62: 3549-3554.
27. Clark EA, Golub TR, Lander ES, et al. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000; 406: 532-535.
28. Yang D-H, Smith ER, Cohen C, et al. Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity. Cancer 2002; 94: 2380-2392.
29. Capo-Chichi CD, Smith ER, Yang D-H, et al. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis. Cancer 2002; 95: 1802-1815.
30. Welsch PL, Lee KL, Gonzalez-Hernandez RM, et al. BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc Natl Acad Sci USA 2002; 99: 7560-7565.
31. Nachtigal P, Gojova A, Semecky V. The role of epithelial and vascular-endothelial cadherin in the differentiation and maintenance of tissue integrity. Acta Med 2001; 44: 83-87.
32. Bremnes RM, Veve R, Hirsch FR, et al. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 2002; 36: 115-124.
33. Elliott BE, Hung WL, Boag AH, et al. The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer. Can J Physiol Pharmacol 2002; 80: 91-102.
34. Hlubek F, Jung A, Kotzor N, et al. Expression of the invasion factor laminin γ2 in colorectal carcinomas is regulated by β-catenin. Cancer Res 2001; 61: 8089-8093.
35. Giannelli G, Falk-Mazillier J, Schiraldi O, et al. Induction of cell migration by matrix metalloproteinase-2 cleavage of laminin-1. Science 1997; 277: 225-228.
36. Giannelli G, Antonaci S. Biological and clinical relevance of laminin-5 in cancer. Clin Exp Med 2001; 18: 439-443.
37. Seftor REB, Seftor EA, Koshikawa N, et al. Cooperative interactions of laminin 5 γ2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 2001; 61: 6322-6327.
38. Scarpino S, Cancellario d'Alena F, DiNapoli A, et al. Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis. J Pathol 2003; 199: 243-250.
39. Sengupta S, Gherardi E, Sellers LA, et al. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. Arterioscl Thromb Vasc Biol 2003; 23: 69-75.
40. Grant DS, Kleinman HK, Goldberg ID, et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993; 90: 1937-1941.
41. Massova I, Kotra LP, Fridman R, et al. Matrix metalloproteinases: structures, evolution, and diversification. FASEB J 1998; 12: 1075-1095.
42. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9: 541-573.
43. Ghosh S, Stack S. Proteolytic modification of laminins: functional consequences. Microsc Res Tech 2000; 51: 238-246.
44. Quaranta V. Motility cues in the tumor microenvironment. Differentiation 2002; 70: 590-598.
45. Katayama M, Sanzen N, Funakoshi A, et al. Laminin γ2-chain fragment in the circulation: a prognostic indicator of epithelial tumor invasion. Cancer Res 2003; 63: 222-229.
46. Hirosaki T, Tsubota Y, Kariya Y, et al. Laminin-6 is activated by proteolytic processin and regulates cellular adhesion and migration differently from laminin-5. J Biol Chem 2002; 277: 49 287-49 295.
47. Fidler IJ. The organ microenvironment and cancer metastasis. Differentiation 2002; 70: 498-505.
48. Wells A, Kassis J, Solava J, et al. Growth factor-induced cell motility in tumor invasion. Acta Oncol 2002; 41: 124-130.
49. Brooks PC, Stromblad S, Sanders LC, et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996; 85: 683-693.
50. Wolf K, Mazo I, Leung H, et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003; 160: 267-277.
51. Stetler-Stevenson WG, Yu AE. Proteases in invasion: matrix metalloproteinases. Semin Cancer Biol 2001; 11: 143-152.
52. Barnhill RL. The biology of melanoma micrometastases. Rec Results Cancer Res 2001; 158: 3-13.
53. Lugassy C, Kleinman HK, Fernandez PM, et al. Human melanoma cell migration along capillary-like structures in vitro: a new dynamic model for studying extravascular migratory metastasis. J Invest Derm 2002; 119: 703-704.
54. Lohi J. Laminin-5 in the progression of carcinomas. Int J Cancer 2001; 94: 763-767.
55. Mercurio AM, Bachelder RE, Chung J, et al. Integrin laminin receptors and breast carcinoma progression. J Mammary Gland Biol Neoplasia 2001; 6: 299-309.
56. Giannelli G, Astigiano S, Antonaci S, et al. Role of the α3β1 and α6β4 integrins in tumor invasion. Clin Exp Med 2002; 19: 217-223.
57. Menard S, Tagliabue E, Colnaghi MI. The 67 kDa receptor as a prognostic factor in human cancer. Breast Cancer Res Treat 1998; 52: 137-145.
58. Lui D, Shriver Z, Oi Y, et al. Dynamic regulation of tumor growth and metastasis by heparan sulfate glycosaminoglycans. Semin Thromb Hemost 2002; 28: 67-78.
59. Kryworuchko M, Diaz-Mitoma F, Kumar A. Interferon-gamma inhibits CD44-hyaluronan interactions in normal human B lymphocytes. Exp Cell Res 1999; 250: 241-252.
60. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat Biotechnol 1995; 1: 27-31.
61. Dunn IF, Heese O, Black PM. Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs. J Neurooncol 2000; 50: 21-137.
62. Kubota Y, Kleinman HK, Martin GR, et al. Role of laminin and basement membrane in the differentiation of human endothelial cells into capillary-like structures. J Cell Biol 1998; 107: 1589-1597.
63. Vlodavsky I, Goldschmidt O, Zcharia E, et al. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Cancer Biol 2002; 12: 121-129.
64. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002; 2: 727-739.
65. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315-328.
66. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285.
67. Pike SE, Yao L, Setsuda J, et al. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth. Blood 1999; 94: 2461-2468.
68. Petitclerc E, Boutaud A, Prestayko A, et al. New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J Biol Chem 2000; 275: 8051-8061.
69. Colorado PC, Torre A, Kamphaus G, et al. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 2000; 60: 2520-2526.
70. Mongiat M, Sweeney SM, San Antonio JD, et al. Endorepellin, a novel inhibitor of angiogenesis derived from the c terminus of perlecan. J Biol Chem 2003; 278: 4238-4249.
71. Risau W, Lemmon V. Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev Biol 1988; 125: 441-450.
72. Stack S, Gonzalex-Gronow M, Pizzo SV. Regulation of plasminogen activation by components of the extracellular matrix. Biochemistry 1990; 29: 4966-4970.
73. Haas TL, Madri JA. Extracellular matrix-driven matrix metalloproteinase production in endothelial cells: implications for angiogenesis. Trends Cardiovasc Med 1999; 9: 70-77.
74. Patarroyo M, Tryggvason K, Virtanen I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Cancer Biol 2002; 12: 197-207.